Han et al. found that dihydroartemisinin promoted immunogenic death in lung cancer mice, increased the expression of related proteins (MHC-I, CRT, and HSP90), and upregulated HMGB1 expression (Han et al., 2023). The gene discussed is HMGB1; the disease is lung cancer.